Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification

Corporate Governance - Twist Bioscience held its 2026 annual meeting of stockholders via an online webcast, focusing on electing directors, conducting a non-binding advisory vote on executive compensation, and ratifying the independent auditor for fiscal 2026 [2] - All three director nominees—Keith Crandell, Jan Johannessen, and Trynka Shineman Blake—were elected, and the advisory vote on executive compensation was approved [6] Meeting Logistics - The meeting was chaired by Lead Independent Director Robert Chess, with attendance from various directors and company officers, including CEO Emily Leproust [3][4] - The board set December 26, 2025, as the record date for determining stockholders entitled to vote, with proxies received for 56,260,506 shares, representing approximately 91.81% of total votes [5][6] Auditor Ratification - Stockholders ratified Ernst & Young LLP as the auditor for fiscal 2026, with a full vote tally to be filed on Form 8-K within four business days [6]